XML 35 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 18,323 $ 21,172 $ 37,059 $ 44,135
General and administrative 4,491 3,849 9,636 8,137
Total operating expenses 22,814 25,021 46,695 52,272
Loss from operations (22,814) (25,021) (46,695) (52,272)
Other income (expense):        
Interest income 998 968 2,185 1,768
Change in fair value of the tranche rights 0 0 (4,796) 0
Other income (expense), net 436 54 (1,658) 1,233
Total other income (expense) 1,434 1,022 (4,269) 3,001
Net loss $ (21,380) $ (23,999) $ (50,964) $ (49,271)
Net loss per share, basic (in USD per share) $ (0.21) $ (0.54) $ (0.51) $ (1.12)
Net loss per share, diluted (in USD per share) $ (0.21) $ (0.54) $ (0.51) $ (1.12)
Weighted-average common shares outstanding, basic (in shares) 101,272,580 44,432,955 99,607,158 44,036,352
Weighted-average common shares outstanding, diluted (in shares) 101,272,580 44,432,955 99,607,158 44,036,352